NVR R40 Pill - brown capsule/oblong, 19mm
Pill with imprint NVR R40 is Brown, Capsule/Oblong and has been identified as Methylphenidate Hydrochloride Extended-Release 40 mg. It is supplied by Sandoz Inc.
Methylphenidate is used in the treatment of ADHD; Narcolepsy; Depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for NVR R40
Methylphenidate Hydrochloride Extended-Release
- Imprint
- NVR R40
- Strength
- 40 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Sandoz Inc.
- Inactive Ingredients
-
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferric oxide yellow,
ferrosoferric oxide,
ferric oxide red
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00078-0372 | Novartis Pharmaceuticals Corporation |
| 00781-2364 | Sandoz Inc. |
Related images for "NVR R40"
More about methylphenidate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,089)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
Patient resources
- Methylphenidate drug information
- Methylphenidate transdermal
- Methylphenidate Chewable Tablets
- Methylphenidate Controlled-Release Tablets
- Methylphenidate Extended-Release Chewable Tablets
Other brands
Concerta, Ritalin, Jornay PM, Ritalin LA, ... +10 more
Professional resources
- Methylphenidate monograph
- Methylin Chewable Tablet (FDA)
- Methylphenidate CD Capsules (FDA)
- Methylphenidate Chewable Tablets (FDA)
- Methylphenidate ER Capsules (FDA)
Other brands
Concerta, Ritalin, Jornay PM, Ritalin LA, ... +10 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.